Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro
Jennifer Bourn,1,2 Maria Cekanova1,2 1Department of Small Animal Clinical Sciences, College of Veterinary Medicine, The University of Tennessee, Knoxville, TN, USA; 2UT-ORNL Graduate School of Genome Science and Technology, The University of Tennessee, Knoxville, TN, USA Purpose: Receptor tyrosine...
Main Authors: | Bourn J, Cekanova M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/cyclooxygenase-inhibitors-potentiate-receptor-tyrosine-kinase-therapie-peer-reviewed-article-DDDT |
Similar Items
-
Effects of tyrosine kinase inhibitor-masitinib mesylate on canine mammary tumour cell lines
by: Ustun-Alkan Fulya, et al.
Published: (2021-07-01) -
Computational Modeling, Docking, Synthesis, Characterization, and in vitro Cyclooxygenase Inhibitory Activity of Some Novel Non-Steroidal Anti-inflammatory Prodrugs
by: Dana Muhammad Hamad Ameen, et al.
Published: (2020-12-01) -
Immunohistochemical expression of Cyclooxygenase-2 in urinary bladder transitional cell carcinomas
by: Moradi Tabriz H, et al.
Published: (2012-07-01) -
Physiopathologie des glomérulopathies : rôle de c-mip et conséquences de son invalidation
by: Mangier, Mélanie
Published: (2015) -
Synthesis and Biological Evaluation of an 18Fluorine-Labeled COX Inhibitor—[18F]Fluorooctyl Fenbufen Amide—For Imaging of Brain Tumors
by: Ying-Cheng Huang, et al.
Published: (2016-03-01)